CNC · CIK 1071739
What Centene Corp told the SEC could break it.
Centene's disclosures all trace to its dependence on government health programs whose rules are being rewritten. The sharpest is the One Big Beautiful Bill Act, passed in July 2025, whose requirements may reduce the number of members eligible for state Medicaid Expansion — striking at its core membership — while the Inflation Reduction Act's redesign of Medicare Part D (eliminating the coverage gap and capping out-of-pocket costs at $2,000 from 2025) reshapes its drug-plan economics. That program exposure is concentrated in specific payers, with its Florida and New York Medicaid contracts each individually about 10% or more of consolidated Medicaid premium revenue in 2025.
3 self-disclosed vulnerabilities, pulled from its own filings — each in the company’s words, with the source. This is the risk register almost nobody reads.
In its own words
What could break it.
Regulatory & policy
- One Big Beautiful Bill Act (OBBBA) Medicaid eligibilityhigh
OBBBA (July 2025) includes requirements that may reduce the number of members eligible for state Medicaid Expansion programs — directly threatening Centene's core Medicaid membership base.
“The One Big Beautiful Bill Act (OBBBA), passed in July 2025, includes requirements that may reduce the number of members eligible for state Medicaid Expansion programs”
SEC filing →As of 2026 - Inflation Reduction Act Medicare Part D redesignmedium
IRA significantly changed Medicare Part D from 2025 — eliminating the coverage gap and capping out-of-pocket costs at $2,000 — impacting Centene's stand-alone PDPs and Medicare Advantage Part D benefit.
“The Inflation Reduction Act (IRA) significantly changed Medicare Part D, impacting stand-alone Medicare PDPs as well as the Part D benefit in many of our Medicare Advantage plans beginning in 2025, most notably by eliminating the coverage gap and capping members' annual out-of-pocket costs at $2,000 in order to provide more predictable and affordable prescription drug coverage for Medicare beneficiaries.”
Customer concentration
- Florida and New York state Medicaid contractsmedium
Medicaid contracts with Florida and New York each individually accounted for ~10%+ of consolidated Medicaid premium revenues in 2025; concentration in two state payers.
“Our Medicaid contracts with the states of Florida and New York accounted for approximately 10% or more of our consolidated Medicaid premium revenues individually in the year ended December 31, 2025.”
SEC filing →As of 2026
The hidden graph
Who it depends on, and who depends on it.
Relationships surfaced from filings — including ones disclosed by the other side, which is how the non-obvious ones come to light.
Its suppliers
“For the twelve months ended December 31, 2025, 2024, and 2023, the primary health plan partners that we served were United, Humana, Elevance, Aetna and Centene.”
Cited →
In the MyPRIA app, this is checked against the companies you actually own.
← World Watch